Pre-Market Power: Take Control of Your Trades

Don’t want emails from us anymore? Click here to unsubscribe

Hello Part-time Trader…👋

Premium Stock Alerts is here with your pre-market cheat sheet. In today's issue, we delve into:

  • Fed's Latest Announcements: Understand the Federal Reserve's recent decisions and economic outlook, and how they might influence the markets.

  • Volume Anomalies: Identify stocks witnessing unusual trading volumes, pointing to potential opportunities or risks.

  • Top Pre-Market Movers: Identify early winners poised for a strong market opening.

  • Market Indices & Sector Overview: Get a snapshot of key market indices and sector performances to gauge the day's potential trends.

  • FDA Approvals & Upcoming Decisions: Keep an eye on the latest FDA approvals and crucial upcoming decisions affecting biotech and pharmaceutical stocks.

Now, let's dive into today's edition for a closer look at the insights and analysis that will shape your trading decisions.


Sponsored

Titanium Shortage Threatens Industry Titan

A titan of the aerospace industry announced it would no longer purchase titanium from Russia, a key supplier. With a global shortage of the lightweight "wonder metal" already in play, aerospace-grade titanium has become particularly scarce.

Will investors find new opportunity amid this titanium crisis?

Happening Today

✓ 08:30 AM ET – Core CPI (MoM) (Mar)

✓ 08:30 AM ET – CPI (YoY) (Mar)

✓ 08:30 AM ET – CPI (MoM) (Mar)

✓ 10:30 AM ET – Crude Oil Inventories

✓ 01:00 PM ET – 10-Year Note Auction

✓ 02:00 PM ET – FOMC Meeting Minutes

PREMARKET SNAPSHOT 📈

Stock Futures hint at a mixed open: NASDAQ leads with a positive outlook, while Dow Jones shows a minor decline.

S&P500

$5209.91

⬆️ 0.14% 

Dow

$38883.67

⬇️ -0.02%

NASDAQ

$18169.904

⬆️ 0.38% 

SECTOR SNAPSHOT 

Today's market action was a mixed bag. While Real Estate soared 1.29%, Financials took a tumble, dipping 0.50%.

NAME

PRICE

%CHANGE

Consumer Discretionary

1,475.21

+0.46% 🟢

Consumer Staples

795.11

+0.51% 🟢

Energy

745.11

+0.06% 🟢

Financials

690.49

-0.50% 🔴

Health Care

1,671.07

+0.39% 🟢

Industrials

1,059.47

-0.22% 🔴

Materials

586.08

+0.27% 🟢

Real Estate

245.95

+1.29% 🟢

Information Technology

3,776.80

+0.16% 🟢

Communication Services

291.54

+0.11% 🟢

Utilities

334.98

+0.55% 🟢


Sponsored

Top 5 "Portfolio Supercharging" Stocks - Free Report from Zacks Investment Research

Zacks has a proven track record for picking big winners. And now, our team of experts has hand-selected, from thousands of companies, the 5 stocks they predict they have outsized gain-potential NOW and in the coming year.

Recent recommendations have climbed as high as +288%. In fact, our newest report could point to even bigger gains. These picks will surprise you and current market conditions could make our new recommendations even more profitable. This special arrangement is good for a limited time only.

I urge you to act now!

Unusual Volume

📈 Selina Hospitality PLC. (SLNA) jumped 96.25% to $0.08 on a whopping 437.46 million shares traded after the company announced that its management team reaffirms its confidence in its strategy as reflected in recent increased equity levels of members of its executive team.

📈 Investors went wild, sending Mobile Global Esports Inc (MGAM) stock soaring 77.78% to $0.22 on a massive volume of 139.57 million shares.

📈 Abnormal activity shook Laser Photonics Corp (LASE), pushing it up 81.12% to $2.59 on a whopping 111.6 million shares traded. This increase followed news that LASE received an order for its LaserTower COMPACT marking and engraving system from L3Harris Technologies, Inc.

📈 Faraday Future Intelligent Electric Inc (FFIE) stock recently closed 24.22% upper at $0.11 on substantial volume of 73.63 million shares. This unusual activity came after the company announced that the establishment of a Middle Eastern sales entity in Dubai, signifying an important milestone in the Company’s expansion plans.

📈 MediaCo Holding Inc (MDIA) increase by 42.05% in a single trading session, with abnormally high trading volume of 71.83 million shares.


Sponsored

NOW is the time to get in on this trillion-dollar megatrend 

Now is the time to position yourself for the next round of explosive growth from what will soon be a trillion-dollar market. But don't chase yesterday's winners!

The AI hype is off the charts and some AI stocks have run so far that they are looking WAY overvalued. When they crash back down to earth, some investors could get hurt. I don't want that to happen to you! So I'm making our new special report on the best AI stocks to own now free for a limited time. 

Get it here.

Premarket Movers

Jaguar Health, Inc. (JAGX) experiences a substantial 31.22% surge in pre-market trading following the approval of all proposals at April 2024 special meeting of stockholders.

Marin Software Incorporated (MRIN) sees a significant 65.48% increase, reaching a pre-market price of $0.47 after the company announced upgrades to its integration with Microsoft Advertising.

Nano Labs Ltd (NA) demonstrates a noteworthy 43.24% surge, with a pre-market price of $2.12 following the filing of annual report on form 20-F for fiscal year 2023.

Pre Market Gainers

Pre Market Change

Pre Market Volume

JAGX

+31.22%

13.05M

MRIN

+65.48%

5.87M

ICCT

+31.02%

5.32M

NA

+43.24%

4.29M

INAB

+24.77%

1.51M

WISA

+5.99%

1.39M

WNW

+50.50%

1.28M

CNXA

+7.49%

388.39K

DAL

+4.48%

272.33K

AAL

+2.51%

244.83K


Sponsored

$50 trade to make today with huge potential!

My favorite trade is an overnight options trade with just $50 or so bucks. I look for a precise setup that has delivered 300%+ gains overnight in the past. I'll show this trade for free in my brand-new presentation I just released. These overnight trades are a ton of fun to put on, easy to do on the side, and you close them fast. The next trade comes out on Thursday.

Click here to access my #1 options strategy for overnight wins starting with $50!

Important FDA 

Recently Announced

Supernus Pharmaceuticals, Inc. (SUPN) recently received news from the FDA regarding SPN-830, a drug targeting the continuous treatment of motor fluctuations in Parkinson’s disease. The FDA issued a Complete Response Letter for SPN-830 on April 8, 2024, indicating further review is needed before potential approval.

AbbVie's (ABBV) ELAHERE, initially granted accelerated approval for platinum-resistant ovarian cancer, saw a significant development on March 22, 2024. The FDA granted full approval for ELAHERE for certain ovarian cancer patients, highlighting its efficacy in this challenging condition.

Bristol-Myers Squibb Co.'s (BMY) Opdivo, in combination with cisplatin-based chemotherapy, achieved a milestone on March 7, 2024. The FDA approved Opdivo as a frontline treatment option for adult patients with unresectable or metastatic urothelial carcinoma, providing new hope for those facing this difficult diagnosis.

Upcoming Announcements

Upcoming on April 23, 2024, ImmunityBio, Inc. (IBRX) awaits a significant FDA decision regarding N-803 plus BCG in high-risk non-muscle-invasive bladder cancer.

On April 28, 2024, Aquestive Therapeutics Inc. (AQST) anticipates a pivotal FDA decision regarding Libervant (diazepam) Buccal Film for the treatment of seizure clusters in children aged between two and five years. The outcome of this decision holds profound implications for pediatric epilepsy management, potentially offering a novel treatment option for a vulnerable patient population.

Lastly, XOMA Corporation (XOMA) is poised for a crucial FDA decision on April 30, 2024, regarding tovorafenib for the treatment of relapsed or progressive pediatric low-grade glioma (pLGG). This announcement represents a milestone in pediatric oncology, with the potential to introduce a much-needed therapeutic option for children facing this challenging diagnosis.

Happy investing,

Maeve Grace
Editor In Cheif
Premium Trade Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.

Join the conversation

or to participate.